Home
Reels
Gruppi
Pagine
Mostra tutto
Gruppi Pagine Events Blogs Funding
Registrati Iscriviti
Night Mode
What Are the Key Challenges Facing the AAV Vector-based Gene Therapy Market?
Despite its promise, the AAV vector-based gene therapy market faces significant challenges. High treatment costs—often exceeding millions of dollars per patient—raise access and reimbursement concerns. Payers are scrutinizing value, and outcomes-based payment models are being explored. The adeno-associated virus vector-based gene therapy market also faces immunogenicity issues....
0 Commenti ·0 condivisioni ·130 Views ·0 Anteprima
Effettua l'accesso per mettere mi piace, condividere e commentare!